The molnupiravir Covid-19 treatment pill was jointly developed by Merck and Ridgeback Biotherapeutics. - Reuters
BANGKOK/JAKARTA (Reuters): Thailand's health minister said on Friday night (Jan 14) the country planned to develop the antiviral pill molnupiravir to combat Covid-19 cases amid rising infections driven by the Omicron variant.
The molnupiravir Covid-19 treatment pill for adult patients at risk of developing severe illness was jointly developed by US-based Merck and Ridgeback Biotherapeutics.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
